Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Sechenov University team builds AI tool that factors menstrual cycle into glucose monitoring | Featured | GxP News
22+ hour, 44+ min ago (308+ words) Researchers at Sechenov University have proposed an approach to improve blood glucose control in women with diabetes. They are building an AI system that analyses blood sugar levels, taking into account not only monitoring data but also physiological factors, including…...
Russia’s Biocad starts final-stage trial of Kadcyla biosimilar for breast cancer | News
1+ mon, 1+ week ago (283+ words) Biocad has opened patient enrollment for a Phase III clinical trial of BCD-237 (trastuzumab emtansine), a potential biosimilar of Swiss drugmaker Hoffmann-La Roche’s original Kadcyla. The drug is designed to treat locally advanced unresectable or metastatic HER2-positive breast cancer. According…...